SCHEMBL7389176

SCHEMBL7389176

[c]1cccc(-c2ncccn2)c1Cn1ccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.47
▸ TBXAS1 P24557 3/20 0.47
▸ CYP11B1 P15538 15/20 0.44
▸ CYP11B2 P19099 11/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ QPCT Q16769 1/20 0.44
▸ CYP4Z1 Q86W10 1/20 0.44
▸ QPCTL Q9NXS2 1/20 0.44
▸ CYP17A1 P05093 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7391276 0.85 CYP11B1 (0.47) CYP19A1TBXAS1CYP11B1CYP11B2POLB
SCHEMBL7390725 0.83 CYP11B1 (0.62) CYP19A1TBXAS1CYP11B1CYP11B2POLB
SCHEMBL7392131 0.80 CYP11B1 (0.51) CYP19A1TBXAS1CYP11B1CYP11B2POLB
SCHEMBL7393797 0.74 CYP2C19 (0.38) MAPTCYP1A2KDM4EBRD4LMNA
SCHEMBL6643796 0.74 CYP2C19 (0.41) POLBMAPTCYP1A2CYP2D6KDM4E
SCHEMBL7381788 0.72 CYP2C19 (0.43) POLBMAPTCYP1A2CYP3A4CYP2D6
SCHEMBL9221130 0.72 CYP11B1 (0.48) CYP19A1TBXAS1CYP11B1CYP11B2POLB
SCHEMBL7392732 0.70 SIGMAR1 (0.41) KDM4ELMNAL3MBTL1
SCHEMBL1865702 0.69 CYP11B1 (0.56) CYP19A1TBXAS1CYP11B1CYP11B2POLB
SCHEMBL6331970 0.68 CYP2D6 (0.40) MAPTCYP1A2CYP3A4CYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060491-A ANTICOAGULANTS; THROMBOEMBOLIC DISORDERS; PROPHYLAXIS DUPONT PHARMACEUTICALS (US) 2000-05-09 — — US disclosed
EP-0993448-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-19 — — EP disclosed
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 — — EP disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 — — US disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
WO-1998057934-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
Send feedback